MTOR and salivary gland cancer: Furthermore, partially response but no toxic effect of using mTOR inhibitor, Temsirolimus on two salivary gland cancers patients with cutaneous metastasis was reported recently [28], providing a strong rationale of applying mTOR inhibitor for SGT treatment.